Cite
HARVARD Citation
Maene, C. et al. (2021). Combination of weekly paclitaxel‐carboplatin plus standard bevacizumab as neoadjuvant treatment in stage IB‐IIB cervical cancer. International journal of gynecological cancer. 31 (6), p. . [Online].